The Cancer Drug Development Forum (CDDF) in collaboration with the Society for Immunotherapy of Cancer (SITC) have the great pleasure to invite you to take part in the 4th Immunotherapy of Cancer Conference (ITOC4) – the leading international conference providing a global platform in Europe for translational research in the field of immuno-oncology.

The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy.
The fourth edition (ITOC4) will take place on Prague, Czech Republic, from 20 to 22 March 2017.
It aims at providing a forum for all professionals working in immunotherapy to discuss early clinical drug development and address the unique challenges of translational research.
The programme will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring and biomarker development.

At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals and the pharmaceutical industry.